| The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: a systematic review C Greenaway, M Pareek, CN Abou Chakra, M Walji, I Makarenko, ... Eurosurveillance 23 (14), 17-00543, 2018 | 100 | 2018 |
| Climate security, risk assessment and military planning CM Briggs International affairs 88 (5), 1049-1064, 2012 | 91 | 2012 |
| Diversity in medical education: data drought and socioeconomic barriers M Walji CMAJ 187 (1), 11-11, 2015 | 35 | 2015 |
| Upholding the integrity of your CMAJ D Kelsall, K Patrick, MB Stanbrook, B Sibbald, K Flegel, E Russell, ... CMAJ 188 (6), E113-E114, 2016 | 19 | 2016 |
| Environmental health risks and vulnerability in post-conflict regions CM Briggs, M Walji, L Anderson Medicine Conflict and Survival 25 (2), 122-133, 2009 | 19 | 2009 |
| Health professionalism must be ensured online and offline M Walji, MB Stanbrook CMAJ 187 (8), 547-547, 2015 | 12 | 2015 |
| Allogeneic hematopoietic cell transplantation after chimeric antigen receptor T Cell therapy in large b cell lymphoma S Fried, R Shouval, M Walji, JR Flynn, R Yerushalmi, N Shem-Tov, ... Transplantation and Cellular Therapy 29 (2), 99-107, 2023 | 10 | 2023 |
| Healthy interpretation M Walji, K Flegel CMAJ 189 (41), E1273-E1273, 2017 | 9 | 2017 |
| Bringing telehealth to humanitarian settings M Walji CMAJ 187 (4), E123-E124, 2015 | 9 | 2015 |
| Environmental health, security, and the longterm consequences of conflict C Briggs, L Anderson, M Walji Conflict, Medicine & Survival 25 (2), 122-133, 2009 | 4 | 2009 |
| Predictors and Implications of Renal Injury in Large Cell Lymphoma Patients Receiving CD19 CAR T Cell Therapy AP Boardman, V Gutgarts, JR Flynn, SM Devlin, A Alarcon Tomas, ... Blood 140 (Supplement 1), 4671-4672, 2022 | 2 | 2022 |
| Adopting global guidelines for air pollution: protecting the health of Canadians M Walji, K Flegel CMAJ 187 (11), 788-788, 2015 | 2 | 2015 |
| Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory Acute Leukemia S Elias, M Walji, S Brown, SM Devlin, EB Papadopoulos, AA Jakubowski, ... Blood 140 (Supplement 1), 10627-10628, 2022 | 1 | 2022 |
| Allogeneic Hematopoietic Cell Transplantation After CAR T-cell Therapy in Large B-cell Lymphoma: Allogeneic-HCT after CAR T-cell therapy. S Fried, R Shouval, M Walji, JR Flynn, R Yerushalmi, N Shem-Tov, ... Transplantation and Cellular Therapy, S2666-6367 (22) 01740, 2022 | 1 | 2022 |
| An evaluation of polatuzumab vedotin for the treatment of patients with diffuse large B-cell lymphoma M Walji, S Assouline Expert Review of Hematology 13 (9), 933-942, 2020 | 1 | 2020 |
| Youth interns in Ethiopia N Hamel, K Muldoon, M Walji The Canadian Nurse 102 (6), 21, 2006 | 1 | 2006 |
| Real-World Experience Study of Belumosudil in Steroid-Refractory Chronic Graft-Versus-Host Disease (cGVHD) Demonstrated High Treatment Response without Significant Toxicities G Raju, M Walji, D Nemirovsky, SM Devlin, I Goldstein, A Singh, ... Transplantation and Cellular Therapy, Official Publication of the American …, 2024 | | 2024 |
| Combined Belumosudil-Ruxolitinib Therapy for the Treatment of Steroid-Refractory Chronic Graft-Versus-Host Disease (cGVHD) Was Associated with Robust Treatment Response and Was … G Raju, M Walji, D Nemirovosky, I Goldstein, SM Devlin, A Singh, ... Transplantation and Cellular Therapy, Official Publication of the American …, 2024 | | 2024 |
| A REPRODUCIBLE INFLAMMATORY BIOMARKER SIGNATURE IDENTIFIES NON-HODGKIN LYMPHOMA PATIENTS AT HIGH RISK OF CAR-T TREATMENT FAILURE ACROSS DIFFERENT COHORTS S Raj, MA Perales, T Fei, J Fein, A Alarcon Tomas, ... BONE MARROW TRANSPLANTATION 58 (SUPP 1), 41-42, 2023 | | 2023 |
| Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory Acute Leukemia S Elias, M Walji, S Brown, SM Devlin, EB Papadopoulos, AA Jakubowski, ... 2023 Tandem Meetings| Transplantation & Cellular Therapy Meetings of ASTCT …, 2023 | | 2023 |
Catherine A. HoganStanford UniversityVerified email at stanford.edu
